ARCHIVES

FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer

This article is from The Cancer Letter archive.

Vol. 14 No. 18 | April 29, 1988

Download PDF Visit The Full Archive

Related Articles

NCAB Member David Koch Gives $100 Million To MIT For New Cancer Research Institute.

October 12, 2007

NCI-Approved Group, Center Clinical Trials Listed

May 25, 2007

NCI Accused Of forsaking Its Mission In House Hearing On Screening Statement

March 18, 1994

NCAB Committee, NCI Split On Starting New Organ Systems Autodigestive Group

February 15, 1985

Trials Could Start Earlier If Model Contract Language Adopted, NCI and CEO Roundtable Say.

December 12, 2008

Clearinghouse Opens With Predictable Controversy; Brown Urges ‘Open Minds’

November 12, 1976